Association Between Menopausal Hormone Therapy and the Risk of Urologic Cancer: A National Population-Based Retrospective Cohort Study in Korea
Jin-Sung Yuk, Sang-Hee Yoon, Dae Yeon Cho, Nuri Oh, Jae Yoon Kim · 2026
Read Association Between Menopausal Hormone Therapy and the Risk of Urologic Cancer: A National Population-Based Retrospective Cohort Study in Korea by Jin-Sung Yuk, Sang-Hee Yoon, Dae Yeon Cho, Nuri Oh, Jae Yoon Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13530410.txt.
Description
Jin-Sung Yuk and co-authors ask, in a 2026 study, whether menopausal hormone therapy changes a woman's risk of cancers of the urinary system, using Korea's national insurance data. Hormone therapy eases menopause, but its cancer ledger is long and organ specific. The urinary side of that ledger was thin.
The data cover 2002 to 2019 from the national review service. Postmenopausal women over forty were split into users and non users of the therapy. Several therapy types were tracked, from combined pills to skin applied estrogen. The analysis adjusted for a long list: body size, other illnesses, income, region, smoking, drinking, exercise, and reproductive history. Survival models then compared cancer rates between the groups. Population scale data can catch small risks that trials miss. For women weighing therapy, organ by organ numbers beat blanket fear or blanket reassurance.
Catalog record
| CREATOR | Jin-Sung Yuk, Sang-Hee Yoon, Dae Yeon Cho, Nuri Oh, Jae Yoon Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |